Risk of Parkinson’s Disease in Restless Leg Syndrome: Evidence from a Population-Based Study (IMAGE)
Caption
An analysis of Korean National Health Insurance data (2002–2019) showed that individuals with restless legs syndrome had a higher risk of Parkinson’s disease (PD). Those treated with dopamine agonists exhibited reduced PD incidence and a delayed onset, suggesting possible neuroprotective effects.
Credit
Professor Jong Hun Kim, Korea University Ansan Hospital, Republic of Korea
Usage Restrictions
Cannot be reused without permission.
License
Original content